[1]陈文韩,谢蓉星,陈少珠.甲状腺激素及骨代谢相关细胞生长因子水平对甲状腺功能亢进症患者的影响[J].国际放射医学核医学杂志,2008,32(4):227-229.
　CHEN Wen-han,XIE Rong-xing,CHEN Shao-zhu.The effect of thyroid hormone and bone metablism-associated growth factor on the patients of hyperthyreosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):227-229.
点击复制

甲状腺激素及骨代谢相关细胞生长因子水平对甲状腺功能亢进症患者的影响(/HTML)
分享到：

《国际放射医学核医学杂志》[ISSN:1673-4114/CN:12-1381/R]

卷:
32
期数:
2008年第4期
页码:
227-229
栏目:
临床核医学
出版日期:
1900-01-01

文章信息/Info

Title:
The effect of thyroid hormone and bone metablism-associated growth factor on the patients of hyperthyreosis
作者:
陈文韩;  谢蓉星;  陈少珠
521000 广东, 广东省潮州市中心医院核医学科
Author(s):
CHEN Wen-han;  XIE Rong-xing;  CHEN Shao-zhu
Department of Nuclear Medicine, Chaozhou Centrical Hospital, Guangzhou 521000, China
关键词:
甲状腺激素; 细胞因子; 骨代谢
Keywords:
Thyroid hormone; Cytokine; Bone metabolism
摘要:
目的 了解甲状腺素激素及部分骨代谢相关细胞因子水平的改变对甲状腺功能亢进症(甲亢)患者骨代谢的影响。方法 采用放免法及化学发光法测定正常人和甲亢患者的血清游离甲状腺素(FT4)游离三碘甲腺原氨酸(FT3)、促甲状腺素(TSH)、胰岛素样生长因子Ⅱ (IGF-Ⅱ)、降钙素(CT)、白细胞介素6(IL-6)和肿瘤坏死因子(TNF)的水平。结果 甲亢患者与正常对照组比较,FT4、FT3和IL-6水平明显增高(t值分别为16.69、11.33、7.92,P<0.01),而TSH、IGF-Ⅱ、CT、TNF水平均明显降低(t值分别为13.08、8.34、5.29、8.75、P<0.01)。结论 甲亢时高浓度的甲状腺激素可导致IL-6产生过多,CT及IGF-Ⅱ131I的消耗储存减少,从而引起骨吸收及骨转换增加,钙、磷代谢紊乱,是造成骨丢失诱发骨质疏松的主要原因。
Abstract:
Objective To evaluate the effect of high concentration of thyroid hormone and cell growth factor content on the bone metabolism of hyperthyreosis.Methods Radiation immunological test and chemiluminescence methods are employed to determinate the content of free triiodothyronine (FT3),free thyroxine (FT4),thyroid stimulating hormone (TSH),insulin-like growth factor Ⅱ (IGF-Ⅱ),calcitonic (CT), interleukin-6 (IL-6) and tumor necrosis factor (TNF) of serum in health adult and parts of hyperthyreosis patients.Results Hyperthyreosis patients have a higher content of FT4,FT3 and IL-6 than those of health adult(t was 16.69,11.33,7.92,respectively,P<0.01),while the content of TSH,IGF-Ⅱ,CT,TNF are obvious deceasing (t was 13.08,8.34,5.29,8.75,respectively,P<0.01).Conclusion In patients with hyperthyreo-sis,high concentration thyroid hormone cause accentuation of protein metabolism,decrease calcium homeostasis by disorders of phosphorus and calcium metabolism,high concentration thyroid hormone and low level CT resulted in bone loss.Decreased IGF-Ⅱ may be the main cause of osteoporosis as the resuh of high concentration thyroid hormone.

参考文献/References:

[1] lagaru A,McDoulgall IR.Treatment of thyrotoxicosis[J].J Nucl Med,2007,48(3):379-389.
[2] Abraham P,Avenell A,Park CM,el al.A systemtic review of drug therapy for Graves’ hyperthyroidism[J].Eur J Endoerinol,2005, 153(4):489-498.
[3] 谭天秩.临床核医学[M].2版.北京:人民卫生出版社,2003: 1218-1250.
[4] Cooper DS.Antithyroid drugs[J].N Engl J Med,2005,352(9):905-917.
[5] Tajiri J,Noguehi S.Antithyroid drugs-induced agranulocytosis: special reference to normal white blood cell count agranulocytosis[J].Thyroid,2004,14(6):459-462.
[6] Brent GA.Clinical practice.Graves’ disease[J].N Ensl J Med, 2008,358(24):2594-2605.

相似文献/References:

[1]邢爽,李明,黄海潇,等.急性辐射损伤的细胞因子联合治疗研究进展[J].国际放射医学核医学杂志,2008,32(1):47.
　XING Shuang,LIMing,HUANG Hai-xiao,et al.Cytokines combination in acute radition injury management[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(4):47.
[2]韩光,周福祥,周云峰.放射性肺损伤的研究[J].国际放射医学核医学杂志,2005,29(6):282.
　HAN Guang,ZHOU Fu-xlang,ZHOU Yun-feng.Research of radiation-induced lung injure[J].International Journal of Radiation Medicine and Nuclear Medicine,2005,29(4):282.
[3]闵锐.辐射损伤防护药及细胞因子治疗研究动态[J].国际放射医学核医学杂志,2004,28(4):173.
　MIN Rui.Status of the research on radioprotective drugs and treatment of radiation damage by cytokines[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):173.
[4]刘强.放射性脑损伤研究现状[J].国际放射医学核医学杂志,2004,28(4):178.
　LIU Qiang.Present investigation of radiation brain injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):178.
[5]闫风琴,鞠桂芝.辐射及细胞因子对p21基因表达的调控作用[J].国际放射医学核医学杂志,2004,28(6):278.
　YAN Feng-qin,JU Gui-zhi.The regulation of radiation and cytokines to p21 gene expression[J].International Journal of Radiation Medicine and Nuclear Medicine,2004,28(4):278.
[6]李杨.放射性肺纤维化分子机制的研究进展[J].国际放射医学核医学杂志,2003,27(2):75.
　LI Yang.Studies on the molecular pathogenesis of radiation pulmonary fibrosis[J].International Journal of Radiation Medicine and Nuclear Medicine,2003,27(4):75.
[7]曹京旭,张旭志.细胞因子与放射性肺损伤[J].国际放射医学核医学杂志,2001,25(4):181.
　CAO Jing-xu,ZHANG Xu-zhi.Cytokines and radiation-induced pulmonary injury[J].International Journal of Radiation Medicine and Nuclear Medicine,2001,25(4):181.
[8]张杰,裴著果.I型骨质疏松症病因学和早期诊断的核医学研究[J].国际放射医学核医学杂志,1998,22(2):59.

备注/Memo

备注/Memo:
收稿日期:2008-01-04。
通讯作者:谢蓉星,E-mail:hzsyxrx@126.com
更新日期/Last Update: 1900-01-01